Annual Long Term Debt
$446.50 M
-$2.00 M-0.45%
31 December 2023
Summary:
Emergent BioSolutions annual long term debt is currently $446.50 million, with the most recent change of -$2.00 million (-0.45%) on 31 December 2023. During the last 3 years, it has fallen by -$394.50 million (-46.91%). EBS annual long term debt is now -46.91% below its all-time high of $841.00 million, reached on 31 December 2020.EBS Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$661.80 M
+$214.80 M+48.05%
30 September 2024
Summary:
Emergent BioSolutions quarterly long term debt is currently $661.80 million, with the most recent change of +$214.80 million (+48.05%) on 30 September 2024. Over the past year, it has increased by +$213.60 million (+47.66%). EBS quarterly long term debt is now -35.88% below its all-time high of $1.03 billion, reached on 30 September 2022.EBS Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EBS Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.5% | +47.7% |
| 3 y3 years | -46.9% | -19.0% |
| 5 y5 years | -43.1% | -18.6% |
EBS Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -46.9% | at low | -35.9% | +48.2% |
| 5 y | 5 years | -46.9% | at low | -35.9% | +48.2% |
| alltime | all time | -46.9% | +4151.6% | -35.9% | +6201.7% |
Emergent BioSolutions Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $661.80 M(+48.1%) |
| June 2024 | - | $447.00 M(+0.1%) |
| Mar 2024 | - | $446.70 M(+0.0%) |
| Dec 2023 | $446.50 M(-0.4%) | $446.50 M(-0.4%) |
| Sept 2023 | - | $448.20 M(+0.0%) |
| June 2023 | - | $448.00 M(+0.1%) |
| Mar 2023 | - | $447.70 M(-0.2%) |
| Dec 2022 | $448.50 M(-44.6%) | $448.50 M(-56.5%) |
| Sept 2022 | - | $1.03 B(+30.1%) |
| June 2022 | - | $793.60 M(-1.0%) |
| Mar 2022 | - | $801.50 M(-1.0%) |
| Dec 2021 | $809.40 M(-3.8%) | $809.40 M(-1.0%) |
| Sept 2021 | - | $817.30 M(-1.0%) |
| June 2021 | - | $825.20 M(-0.9%) |
| Mar 2021 | - | $833.10 M(-0.9%) |
| Dec 2020 | $841.00 M(+5.3%) | $841.00 M(-0.9%) |
| Sept 2020 | - | $848.50 M(+11.9%) |
| June 2020 | - | $758.10 M(-0.6%) |
| Mar 2020 | - | $762.90 M(-4.4%) |
| Dec 2019 | $798.40 M(+1.8%) | $798.40 M(-1.8%) |
| Sept 2019 | - | $813.30 M(-2.1%) |
| June 2019 | - | $830.40 M(+13.4%) |
| Mar 2019 | - | $732.40 M(-6.6%) |
| Dec 2018 | $784.50 M(+5711.1%) | $784.50 M(+5713.3%) |
| Sept 2018 | - | $13.49 M(+0.1%) |
| June 2018 | - | $13.48 M(+0.1%) |
| Mar 2018 | - | $13.47 M(-0.2%) |
| Dec 2017 | $13.50 M(-94.6%) | $13.50 M(-94.6%) |
| Sept 2017 | - | $248.99 M(+0.1%) |
| June 2017 | - | $248.69 M(+0.1%) |
| Mar 2017 | - | $248.39 M(+0.1%) |
| Dec 2016 | $248.09 M(+0.5%) | $248.09 M(+0.1%) |
| Sept 2016 | - | $247.79 M(+0.2%) |
| June 2016 | - | $247.39 M(+0.1%) |
| Mar 2016 | - | $247.19 M(+0.1%) |
| Dec 2015 | $246.89 M | $246.89 M(-2.4%) |
| Sept 2015 | - | $253.00 M(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2015 | - | $253.00 M(+0.8%) |
| Mar 2015 | - | $251.00 M(0.0%) |
| Dec 2014 | $251.00 M(+304.8%) | $251.00 M(0.0%) |
| Sept 2014 | - | $251.00 M(0.0%) |
| June 2014 | - | $251.00 M(0.0%) |
| Mar 2014 | - | $251.00 M(+304.8%) |
| Dec 2013 | $62.00 M(+6.3%) | $62.00 M(+12.8%) |
| Sept 2013 | - | $54.95 M(-2.0%) |
| June 2013 | - | $56.07 M(-2.0%) |
| Mar 2013 | - | $57.19 M(-1.9%) |
| Dec 2012 | $58.30 M(+7.8%) | $58.30 M(-1.0%) |
| Sept 2012 | - | $58.87 M(+1.2%) |
| June 2012 | - | $58.14 M(+1.0%) |
| Mar 2012 | - | $57.59 M(+6.5%) |
| Dec 2011 | $54.09 M(+78.9%) | $54.09 M(+10.7%) |
| Sept 2011 | - | $48.87 M(+68.1%) |
| June 2011 | - | $29.07 M(-2.0%) |
| Mar 2011 | - | $29.66 M(-1.9%) |
| Dec 2010 | $30.24 M(-32.7%) | $30.24 M(-16.5%) |
| Sept 2010 | - | $36.23 M(-1.9%) |
| June 2010 | - | $36.91 M(-16.4%) |
| Mar 2010 | - | $44.16 M(-1.7%) |
| Dec 2009 | $44.93 M(+25.0%) | $44.93 M(+119.2%) |
| Sept 2009 | - | $20.50 M(-3.5%) |
| June 2009 | - | $21.25 M(-39.6%) |
| Mar 2009 | - | $35.21 M(-2.0%) |
| Dec 2008 | $35.94 M(-15.6%) | $35.94 M(-9.4%) |
| Sept 2008 | - | $39.65 M(-2.3%) |
| June 2008 | - | $40.60 M(-2.6%) |
| Mar 2008 | - | $41.70 M(-2.1%) |
| Dec 2007 | $42.59 M(+35.8%) | $42.59 M(-2.1%) |
| Sept 2007 | - | $43.49 M(+44.9%) |
| June 2007 | - | $30.02 M(-2.4%) |
| Mar 2007 | - | $30.75 M(-2.0%) |
| Dec 2006 | $31.37 M(+198.7%) | $31.37 M(-3.6%) |
| Sept 2006 | - | $32.55 M(+210.0%) |
| Dec 2005 | $10.50 M(-11.2%) | $10.50 M(-11.2%) |
| Dec 2004 | $11.82 M | $11.82 M |
FAQ
- What is Emergent BioSolutions annual long term debt?
- What is the all time high annual long term debt for Emergent BioSolutions?
- What is Emergent BioSolutions annual long term debt year-on-year change?
- What is Emergent BioSolutions quarterly long term debt?
- What is the all time high quarterly long term debt for Emergent BioSolutions?
- What is Emergent BioSolutions quarterly long term debt year-on-year change?
What is Emergent BioSolutions annual long term debt?
The current annual long term debt of EBS is $446.50 M
What is the all time high annual long term debt for Emergent BioSolutions?
Emergent BioSolutions all-time high annual long term debt is $841.00 M
What is Emergent BioSolutions annual long term debt year-on-year change?
Over the past year, EBS annual long term debt has changed by -$2.00 M (-0.45%)
What is Emergent BioSolutions quarterly long term debt?
The current quarterly long term debt of EBS is $661.80 M
What is the all time high quarterly long term debt for Emergent BioSolutions?
Emergent BioSolutions all-time high quarterly long term debt is $1.03 B
What is Emergent BioSolutions quarterly long term debt year-on-year change?
Over the past year, EBS quarterly long term debt has changed by +$213.60 M (+47.66%)